SCIENTIFIC PROGRAMME

Thursday, October 20th Friday, October 21st
8:30 - 9:00 E - NUTS, INFLAMMATION AND OXIDATION
9:00 - 9:30
9:30 - 10:00 F - NUTS, CARDIOVASCULAR DISEASE OUTCOMES
10:00 - 10:30
10:30 - 11:00 Coffee break
11:00 - 11:30 G - NUT CONSUMPTION, AGEING AND COGNITION
11:30 - 12:00
12:00 - 12:30 Lunch H - NUTS, DRIED FRUITS AND CANCER
12:30 - 1:00
1:00 - 1:30 Opening (1:20 – 1:30) Lunch
1:30 - 2:00 A - NUTS, ENERGY BALANCE AND BODY WEIGHT
2:00 - 2:30 I - DRIED FRUIT AND HEALTH
2:30 - 3:00
3:00 - 3:30 B - NUTS, INSULIN RESISTANCE AND DIABETES Coffee break
3:30 - 4:00 J - NOVEL LINES OF RESEARCH
4:00 - 4:30
4:30 - 5:00 Coffee break
5:00 - 5:30 C - NUTS, LIPOPROTEINS, DYSLIPIDEMIA Concluding remarks + Cocktail
5:30 - 6:00
6:00 - 6:30 D - NUTS AND THE GASTROINTESTINAL SYSTEM
6:30 - 7:00
7:00 - 7:30 Gala dinner

Below you will find the scientific programme of the meeting including the main topics and subtopics

A - NUTS, ENERGY BALANCE AND BODY WEIGHT (1h30')

Chairs: Joan Sabaté & Jordi Salas-Salvadó

Energy availability of nuts. David J Baer, USA
Nuts, appetite, satiety and mechanisms of energy balance. Michelle Dalton, UK
Nuts and body weight: evidence from epidemiologic studies and clinical trials. Frank Hu, USA


B - NUTS, INSULIN RESISTANCE AND DIABETES (1h30')

Chairs: Frank Hu & Anoop Misra

Nuts and diabetes prevention: Cohort studies and clinical trials. Jordi Salas-Salvadó, Spain
Nuts and insulin resistance and diabetes management: clinical trials. Cyril Kendall, Canada
Effect of nuts on insulin resistance and glycemic control: possible mechanisms. David Jenkins, Canada


C - NUTS, LIPOPROTEINS, DYSLIPIDEMIA (1h)

Chairs: Emilio Ros & Linda Tapsell

Effect of nuts on the lipid profile and lipoprotein particle number and size: mechanisms. Penny Kris-Etherton, USA
Lipid effects of nuts: clinical trials and cohort studies. Marta Guasch-Ferré, USA


D - NUTS AND THE GASTROINTESTINAL SYSTEM (1h)

Chairs: John Sievenpiper & Crystal Haskell-Ramsay

Bioavailability of nut phytochemicals. Giuseppina Mandalari, Italy
Nut consumption and gut microbiota: effects and metabolic consequences. David J Baer, USA


E - NUTS, INFLAMMATION AND OXIDATION (1h)

Chairs: Penny Kris-Etherton & Aleix Sala-Vila

Importance of fat and antioxidants in nuts on inflammation and oxidative stress. Differences among nut types. Nágila R T Damasceno, Brazil
Effect of nuts on biomarkers of oxidation and inflammation: evidence from cohort studies and clinical trials. Sujatha Rajaram, USA


F - NUTS, CARDIOVASCULAR DISEASE OUTCOMES (1h)

Chairs: Heinz Freisling & Noushin Mohammadifard

Nuts consumption and cardiac endpoints (MI, atrial fibrillation and heart failure) and mortality. John Sievenpiper, Canada
Nut consumption, stroke and peripheral artery disease. Dagfinn Aune, Norway


G - NUT CONSUMPTION, AGEING AND COGNITION (1h)

Chairs: Joan Sabaté & Stephanie Nishi

Nuts and brain health in adolescents. Jordi Júlvez, Spain
Effects of nuts on cognitive decline and dementia. Emilio Ros, Spain
Nut consumption and ageing: possible mechanisms. Aleix Sala-Vila, Spain


H - NUTS, DRIED FRUITS AND CANCER (1h)

Chairs: Cyril Kendall

Nuts consumption and cancer incidence and mortality. Heinz Freisling, France
Dried fruit consumption and cancer. Bradley Bolling, USA


I - DRIED FRUIT AND HEALTH (1h)

Chairs: David Jenkins & Marta Guasch-Ferré

Dried fruits for cardiometabolic health. Penny Kris-Etherton, USA
Dried fruits: bioactives, bioavailability and gastrointestinal health. Cesarettin Alsalvar, Turkey


J - NOVEL LINES OF RESEARCH (1h30')

Chairs: Jordi Salas-Salvadó & Cesarettin Alasalvar

Nuts and reproductive health. Albert Salas-Huetos, USA
Nuts consumption and environmental sustainability. Joan Sabaté, USA
Nuts as components of healthy dietary patterns. Linda Tapsell, Australia